Group One Trading, L.P. Aytu Biopharma, Inc Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.15 - $4.0 $60 - $1,600	-400 Reduced 0.99%	40,190 $7,000
Q2 2022 Aug 11, 2022	BUY	$0.46 - $1.08 $14,766 - $34,668	32,100 Added 378.09%	40,590 $28,000
Q1 2022 May 12, 2022	BUY	$1.08 - $1.55 $5,508 - $7,905	5,100 Added 150.44%	8,490 $9,000
Q4 2021 Feb 11, 2022	SELL	$1.35 - $2.95 $25,115 - $54,881	-18,604 Reduced 84.59%	3,390 $5,000
Q3 2021 Nov 12, 2021	BUY	$2.78 - $5.12 $4,542 - $8,366	1,634 Added 8.03%	21,994 $63,000
Q2 2021 Aug 10, 2021	BUY	$4.73 - $7.56 $71,394 - $114,110	15,094 Added 286.63%	20,360 $102,000
Q1 2021 May 12, 2021	BUY	$6.23 - $9.88 $32,788 - $51,998	5,263 Added 175433.33%	5,266 $40,000
Q4 2020 Feb 10, 2021	BUY	$5.98 - $13.5 $17 - $40	3 New	3 $0

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.